MKI67 and neoplasm: In vivo expansion of TAII was indicated by co-staining IHC analysis showing proliferating (Ki67+) CD3+ cells in both liver, spleen and tumor (Fig. 2f) and confirmed by TCR clonotyping analysis of the injected AII cells and tumors (Fig. 2g, P < 0.001).